18,400 resources
By Version
By Authority
Start Prev Rows 7600 - 7800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1954 | La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1955 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1956 | La Crosse Virus Diseases (Tests for La Crosse Virus Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1957 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1958 | Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1965 | Encephalomyelitis (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1967 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1969 | Hepatitis D Virus Infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1970 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1971 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1972 | Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1976 | Baylisascariasis (Tests for Baylisascaris species Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1979 | Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1981 | California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1983 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1984 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1985 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1986 | Pregnant (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1990 | Abscess (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1993 | Pathologic Fractures [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1995 | Granulomas (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1997 | Skin Lesions (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2000 | Lymphocytic Choriomeningitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2006 | Angiostrongyliasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2018 | Interpretation of an Observation (High) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2019 | Interpretation of an Observation (Low) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2026 | Animal Bite or Scratch [Cat] (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2028 | Bartonellosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2033 | Bartonella henselae infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2034 | Bartonella quintana infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2053 | Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2055 | Cystic Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2057 | Alveolar Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2063 | Genital Warts (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2065 | Diphyllobothriasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2072 | Pelvic Inflammatory Disease (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2073 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2074 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2076 | Lower Abdominal Tenderness (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2081 | Leukocytosis (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2084 | Pelvic Abscess (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2088 | Nongonococcal Urethritis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2090 | Urethritis (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2092 | Urethral discharge (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2094 | Dysuria (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2100 | Rhinitis (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2102 | Pleuritis (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2107 | Methemoglobinemia (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2108 | Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2111 | Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2113 | Fetal Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2115 | Cleft Lip Alone (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2118 | Cleft Palate Alone (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2120 | Cleft Lip with Cleft Palate (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2123 | Spina Bifida (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2125 | Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2127 | Fetal Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2130 | Bacteremia (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2132 | Gastroschisis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2134 | Fatal Familial Insomnia (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2136 | Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2138 | Prion Disease (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2141 | Phenylketonuria (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2148 | Limb Reduction (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2151 | Congenital Hearing Loss (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2155 | Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) | active | 2023-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) | active | 2023-06 | hl7 |
FHIR